Some like it hot! Structure of receptor for hot chili pepper and pain revealedMay 20, 2008You can now not only feel the spicy kick of a jalapeno pepper, you can also see it in full 3D, thanks to researchers at Baylor College of Medicine in Houston. Using sophisticated equipment, the research team led by Dr Theodore G. Wensel, professor of biochemistry and molecular biology at BCM, generated the first three dimensional view of the protein that allows you to sense the heat of a hot pepper. The report appears in the current issue of the Proceedings of the National Academy of Sciences. "This protein, known as TRPV1, not only senses spicy foods, but also makes it possible to feel real heat and the pain and inflammation related to other medical conditions," said Wensel, senior author on the study. "This method of viewing the protein now gives us the chance to clearly see the functional relationship between outside stimuli and the nerve cell."
The outside stimulus used in this study was the heat of a chili pepper. It has been known for years that the burning sensation results from the action of a chemical known as capsaicin on TRPV1 found on the nerve cell membrane. TRPV1 is an ion channel, a tiny pore on the cell membrane that allows chemicals such as calcium to flux in and out. "Any time you feel a burn or pain sensation, it is mediated by a TRPV1 channel. Different levels of heat are mediated by different TRP channels," said Dr. Vera Moiseenkova-Bell, a postdoctoral associate in Wensel's laboratory at BCM and first author of the study. "They are all related but each is regulated in a different manner." Wensel said the three-dimensional image of TRPV1 revealed surprising information about its structure. It is made up of a pore domain embedded in the cell membrane, and a "hanging basket" of regulatory domains that extend into the interior of the cell. "It's an unusual thing. There is a whole hollow 'basket' area but we don't know what's that's for," Wensel said. "Now the search is on to understand how the 'basket' area regulates the channel." Isolating TRPV1 gives researchers an idea of how other channels are structured as well. "Visualization of TRPV1 gives us insight on other TRP channels since they are structurally similar," said Moiseenkova-Bell. "Pharmaceutical companies target these TRP channels to make sure the drug binds properly. With this first structure we can start to build models of binding sites and hopefully in the future design more effective pharmaceuticals for a wide range of medical conditions." Studying these channels is nothing new. In the past, scientists could measure the activity in the cells but it was unclear what each channel was responding to. Determining which proteins interacted with TRPV1, however, required Wensel's lab to create a purified model. The protein had to be removed from cells, purified, and reconstituted in a synthetic membrane so researchers could control channel activity. "Since calcium is involved in cell signaling, following the calcium movement confirmed the protein is active," said Wensel. "We are the first group to purify a TRPV1 channel and control what goes in and out when the channel opens." Baylor College of Medicine | |||||||||||||||||||||
|
Related Cell Membrane News Articles Scientists uncover Ebola cell-invasion strategy University of Texas Medical Branch at Galveston researchers have discovered a key biochemical link in the process by which the Ebola Zaire virus infects cells - a critical step to finding a way to treat the deadly disease produced by the virus. Century-old rule of chemistry overturned -- major implications for drug delivery A new study by research chemists at the University of Warwick has challenged a century old rule of pharmacology that defined how quickly key chemicals can pass across cell walls. New method to overcome multiple drug resistant diseases developed by Stanford researchers Many drugs once considered Charles Atlases of the pharmaceutical realm have been reduced to the therapeutic equivalent of 97-pound weaklings as the diseases they once dispatched with ease have developed resistance to them. N.Y. Research Team Discovers How Antidepressants and Cocaine Interact with Brain Cell Targets In a first, scientists from Weill Cornell Medical College and Columbia University Medical Center have described the specifics of how brain cells process antidepressant drugs, cocaine and amphetamines. These novel findings could prove useful in the development of more targeted medication therapies for a host of psychiatric diseases, most notably in the area of addiction. Researchers analyze how new anti-MRSA abtibiotics function A new paper by Shahriar Mobashery, Navari Family Professor in Life Sciences at the University of Notre Dame, and researchers in his lab provides important insights into promising new antibiotics aimed at combating MRSA. Bacteria reveal secret of adaptation at Evolution Canyon Bacteria living on opposite sides of a canyon have evolved to cope with different temperatures by altering the make-up of their 'skin', or cell membranes. Scientists have found that bacteria change these complex and important structures to adapt to different temperatures by looking at the appearance of the bacteria as well as their genes. NIST membrane model may unlock secrets of early-stage Alzheimer's Researchers at the National Institute of Standards and Technology (NIST) and three collaborating institutions are using a new laboratory model of the membrane surrounding neurons in the brain to study how a protein long suspected of a role in early-stage Alzheimer's disease actually impairs a neuron's structure and function. HIV conquers immune system faster than previously realized New research into the earliest events occurring immediately upon infection with HIV-I shows that the virus deals a stunning blow to the immune system earlier than was previously understood. Researchers catch ion channels in their opening act Each thought or action sends a million electrical signals pulsing through your body. At the heart of the process of generating these electrical impulses is the ion channel. MIT researchers see alternative to common colorectal cancer drug A compound that accumulates in cells more readily than a commonly used colorectal cancer drug may be just as useful in treating colorectal tumors, but with fewer side effects, MIT researchers have found. More Cell Membrane News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||